|Articles|April 14, 2021
- Pharmaceutical Executive-04-01-2021
- Volume 41
- Issue 4
Pharmaceutical Executive, April 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive April 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
The Challenges of Worker Qualification Management in Pharmaover 5 years ago
Years in the Making: A Repeat Recognition—Uninterruptedover 5 years ago
Pharm Exec at 40 (1990-1993)over 5 years ago
The Power of Parityover 5 years ago
No Limits to Science, Or Selfover 5 years ago
In Silico in Sight as Biopharma Game-Changerover 5 years ago
Long-View Innovation Hopes for Pharma Policy in the EUAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5